Cargando…

Intra‐ and inter‐breed variation in immune response to acute and sub‐chronic Salmonella infection and commercial immune‐stimulant in two‐layer breeds

Salmonella is one of the most hazardous diseases in poultry farms. Markedly, the application of active immunostimulants is illustrated as potential protective agents against infection in poultry farms. Thus, this work aimed to explore inter‐ and intra‐breed variation in response to acute and subchro...

Descripción completa

Detalles Bibliográficos
Autores principales: Khatab, Shymaa A., Hemeda, Shabaan A., El‐Nahas, Abeer F., Abd El Naby, Walaa S.H., Hassan, Sabry, Alorabi, Jamal A., Dawood, Mahmoud A.O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604112/
https://www.ncbi.nlm.nih.gov/pubmed/34498429
http://dx.doi.org/10.1002/vms3.621
_version_ 1784601886579490816
author Khatab, Shymaa A.
Hemeda, Shabaan A.
El‐Nahas, Abeer F.
Abd El Naby, Walaa S.H.
Hassan, Sabry
Alorabi, Jamal A.
Dawood, Mahmoud A.O.
author_facet Khatab, Shymaa A.
Hemeda, Shabaan A.
El‐Nahas, Abeer F.
Abd El Naby, Walaa S.H.
Hassan, Sabry
Alorabi, Jamal A.
Dawood, Mahmoud A.O.
author_sort Khatab, Shymaa A.
collection PubMed
description Salmonella is one of the most hazardous diseases in poultry farms. Markedly, the application of active immunostimulants is illustrated as potential protective agents against infection in poultry farms. Thus, this work aimed to explore inter‐ and intra‐breed variation in response to acute and subchronic Salmonella enteritidis infection in two‐layer breeds (one commercial [Hy‐line strain] and another native [Fayoumi breed]). Besides exploring the possible protective effect of a commercial immune modulator (STIMULAN) on the two breeds during the acute infection. The ELISA antibody titer in sub‐chronic infections and the expression analysis of some selected genes (IL‐1β, LITAF, TGF‐β, HSP90 and HSP70) are used as the clinical signs for acute infections to assess the possible protective role of a commercial immunomodulator (STIMULAN). Five groups were used during the acute experiment: G1—control; G2a—susceptible; G2b—resistant birds, G3—which received STIMULAN and G4—which received the infection + STIMULAN. The groups with sub‐chronic infections include G1 (control), G2 (high antibody titer) and G3 (low antibody titer). The gene expressions among the susceptible birds during acute infection of both breeds are nearly similar. They only differ in the expression of HSP90 in the Fayoumi breed. However, the resistant birds vary in their gene expression profile. The effect of STIMULAN as a feed additive in non‐infected birds was an up‐regulation of LITAF, TGF‐β, HSP90 in Fayoumi. Moreover, a powerful stimulatory role was observed when both breeds were infected. Both breeds were asymptomatic during the sub‐chronic infection. Although, the increased expression of inflammatory‐related genes in the Hy‐line was considered as an indication of infection persistence. Fayoumi is capable of immune clearance for this infection. Thus, the Fayoumi breed is more resistant to acute Salmonella infection. HSP90 plays a vital role in its resistance. We recommend the use of STIMULAN as an immunomodulator during Salmonella infection.
format Online
Article
Text
id pubmed-8604112
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-86041122021-11-24 Intra‐ and inter‐breed variation in immune response to acute and sub‐chronic Salmonella infection and commercial immune‐stimulant in two‐layer breeds Khatab, Shymaa A. Hemeda, Shabaan A. El‐Nahas, Abeer F. Abd El Naby, Walaa S.H. Hassan, Sabry Alorabi, Jamal A. Dawood, Mahmoud A.O. Vet Med Sci Original Articles Salmonella is one of the most hazardous diseases in poultry farms. Markedly, the application of active immunostimulants is illustrated as potential protective agents against infection in poultry farms. Thus, this work aimed to explore inter‐ and intra‐breed variation in response to acute and subchronic Salmonella enteritidis infection in two‐layer breeds (one commercial [Hy‐line strain] and another native [Fayoumi breed]). Besides exploring the possible protective effect of a commercial immune modulator (STIMULAN) on the two breeds during the acute infection. The ELISA antibody titer in sub‐chronic infections and the expression analysis of some selected genes (IL‐1β, LITAF, TGF‐β, HSP90 and HSP70) are used as the clinical signs for acute infections to assess the possible protective role of a commercial immunomodulator (STIMULAN). Five groups were used during the acute experiment: G1—control; G2a—susceptible; G2b—resistant birds, G3—which received STIMULAN and G4—which received the infection + STIMULAN. The groups with sub‐chronic infections include G1 (control), G2 (high antibody titer) and G3 (low antibody titer). The gene expressions among the susceptible birds during acute infection of both breeds are nearly similar. They only differ in the expression of HSP90 in the Fayoumi breed. However, the resistant birds vary in their gene expression profile. The effect of STIMULAN as a feed additive in non‐infected birds was an up‐regulation of LITAF, TGF‐β, HSP90 in Fayoumi. Moreover, a powerful stimulatory role was observed when both breeds were infected. Both breeds were asymptomatic during the sub‐chronic infection. Although, the increased expression of inflammatory‐related genes in the Hy‐line was considered as an indication of infection persistence. Fayoumi is capable of immune clearance for this infection. Thus, the Fayoumi breed is more resistant to acute Salmonella infection. HSP90 plays a vital role in its resistance. We recommend the use of STIMULAN as an immunomodulator during Salmonella infection. John Wiley and Sons Inc. 2021-09-08 /pmc/articles/PMC8604112/ /pubmed/34498429 http://dx.doi.org/10.1002/vms3.621 Text en © 2021 The Authors. Veterinary Medicine and Science published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Khatab, Shymaa A.
Hemeda, Shabaan A.
El‐Nahas, Abeer F.
Abd El Naby, Walaa S.H.
Hassan, Sabry
Alorabi, Jamal A.
Dawood, Mahmoud A.O.
Intra‐ and inter‐breed variation in immune response to acute and sub‐chronic Salmonella infection and commercial immune‐stimulant in two‐layer breeds
title Intra‐ and inter‐breed variation in immune response to acute and sub‐chronic Salmonella infection and commercial immune‐stimulant in two‐layer breeds
title_full Intra‐ and inter‐breed variation in immune response to acute and sub‐chronic Salmonella infection and commercial immune‐stimulant in two‐layer breeds
title_fullStr Intra‐ and inter‐breed variation in immune response to acute and sub‐chronic Salmonella infection and commercial immune‐stimulant in two‐layer breeds
title_full_unstemmed Intra‐ and inter‐breed variation in immune response to acute and sub‐chronic Salmonella infection and commercial immune‐stimulant in two‐layer breeds
title_short Intra‐ and inter‐breed variation in immune response to acute and sub‐chronic Salmonella infection and commercial immune‐stimulant in two‐layer breeds
title_sort intra‐ and inter‐breed variation in immune response to acute and sub‐chronic salmonella infection and commercial immune‐stimulant in two‐layer breeds
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604112/
https://www.ncbi.nlm.nih.gov/pubmed/34498429
http://dx.doi.org/10.1002/vms3.621
work_keys_str_mv AT khatabshymaaa intraandinterbreedvariationinimmuneresponsetoacuteandsubchronicsalmonellainfectionandcommercialimmunestimulantintwolayerbreeds
AT hemedashabaana intraandinterbreedvariationinimmuneresponsetoacuteandsubchronicsalmonellainfectionandcommercialimmunestimulantintwolayerbreeds
AT elnahasabeerf intraandinterbreedvariationinimmuneresponsetoacuteandsubchronicsalmonellainfectionandcommercialimmunestimulantintwolayerbreeds
AT abdelnabywalaash intraandinterbreedvariationinimmuneresponsetoacuteandsubchronicsalmonellainfectionandcommercialimmunestimulantintwolayerbreeds
AT hassansabry intraandinterbreedvariationinimmuneresponsetoacuteandsubchronicsalmonellainfectionandcommercialimmunestimulantintwolayerbreeds
AT alorabijamala intraandinterbreedvariationinimmuneresponsetoacuteandsubchronicsalmonellainfectionandcommercialimmunestimulantintwolayerbreeds
AT dawoodmahmoudao intraandinterbreedvariationinimmuneresponsetoacuteandsubchronicsalmonellainfectionandcommercialimmunestimulantintwolayerbreeds